Post-COVID-19 Condition: Clinical Trials

1 trial for Post-COVID-19 Condition, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Not yet recruiting 1

Follow Post-COVID-19 Condition: new trials by email Literature Review of Post-COVID-19 Condition trials Research Report on Post-COVID-19 Condition

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition
REGENECYTE, Placebo - Long COVID, Post-COVID-19 Condition
Phase 3Not yet recruitingStemCyte, Inc.602026-03-312025-09-23

Narrower conditions

Post-Acute COVID-19 Syndrome (1)

Broader conditions

COVID-19 (1)  ·  Chronic Disease (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Disease Attributes (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  Post-Infectious Disorders (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)

Sponsors

StemCyte, Inc. (1)